Viewing Study NCT02781727


Ignite Creation Date: 2025-12-25 @ 5:12 AM
Ignite Modification Date: 2026-01-03 @ 8:35 PM
Study NCT ID: NCT02781727
Status: COMPLETED
Last Update Posted: 2022-01-04
First Post: 2016-05-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
Sponsor: Ascendis Pharma Endocrinology Division A/S
Organization: